13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2023-07-06 Event — SEC 0001104659-23-078773 →

Fortress Biotech, Inc. Checkpoint Therapeutics, Inc.

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
11 filings by this filer
10 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on Checkpoint Therapeutics, Inc.

FiledFormFilerStakeShares
2025-01-03 SCHEDULE Fortress Biotech, Inc. 13.50% 6,903,749 view →
2024-10-01 SC Fortress Biotech, Inc. view →

Other Filings by Fortress Biotech, Inc.

FiledFormIssuerStakeShares
2026-01-06 SCHEDULE AVENUE THERAPEUTICS, INC. ATXI 13.40% 439,955 view →
2026-01-05 SCHEDULE MUSTANG BIO, INC. MBIO 8.00% 537,243 view →
2025-10-01 SCHEDULE MUSTANG BIO, INC. MBIO 4.00% 258,858 view →
2025-04-02 SCHEDULE AVENUE THERAPEUTICS, INC. ATXI 10.30% 328,746 view →
2025-04-02 SCHEDULE MUSTANG BIO, INC. MBIO 7.90% 199,191 view →
2025-01-03 SCHEDULE Checkpoint Therapeutics, Inc. 13.50% 6,903,749 view →
2025-01-03 SCHEDULE MUSTANG BIO, INC. MBIO 12.40% 6,569,450 view →
2025-01-03 SCHEDULE AVENUE THERAPEUTICS, INC. ATXI 13.80% 295,022 view →
2024-10-01 SC Checkpoint Therapeutics, Inc. view →
2019-05-17 SC MUSTANG BIO, INC. MBIO view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →